In a new study, researchers from the University of Copenhagen have mapped how a potent neuropeptide binds to a brain receptor involved in causing human pain. The researchers expect that the mechanism could be exploited as a new avenue for painkilling medicine.
Patients who experience chest pain and have abnormal results on a cardiac stress test but who do not have blocked arteries often experience changes in their symptoms and stress test results over time, according to research presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC).
The results of VOYAGER PAD found that people with peripheral artery disease (PAD) who took the blood thinner rivaroxaban with aspirin after undergoing lower extremity revascularization -- a procedure to treat blocked arteries in the leg -- had a significant reduction in the risk of major adverse limb and cardiovascular events when compared with those receiving aspirin alone, according to a subgroup analysis from VOYAGER PAD presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC).
New studies highlighting the chronic health burden of oversized breasts outline the long-term benefits of breast reduction surgery to health, levels of wellbeing, and quality of life. The 12-year study compared feedback from more than 200 Australian women before and after having breast reduction surgery for the painful condition of breast hypertrophy - calling to task private and public health system funding for the surgery.
Scientists have identified a specific type of sensory nerve ending in the gut and how these communicate pain or discomfort to the brain, paving the way for targeted treatments for common conditions like ulcerative colitis, irritable bowel syndrome or chronic constipation. While understanding of the gut's neurosensory abilities has grown rapidly, two great mysteries have been where and how different types of sensory nerve endings in the gut lie.
More than 90% of the legal marijuana products offered in medical dispensaries are much stronger than what clinical studies have shown that doctors recommend for chronic pain relief, according to a study published in the March 26 online edition of the journal PLOS ONE.
A pair of new studies led by University of Alberta pediatricians indicate that parents are more reluctant to have opioids prescribed for their children than doctors are to prescribe them.
The need for accurate and informative labeling of hemp and hemp-derived cannabidiol (CBD) products is a critical public health issue.
Through studies of rats, researchers from the University of Copenhagen may have found the reason behind of a large drop in blood pressure in patients receiving intravenous pain medication.
It could be an important step forward in the improvement of pain therapy: Thanks to newly developed molecular probes, the behavior of individual opioid receptors can now be studied in detail.